Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sulfur hexafluoride
Drug ID BADD_D02096
Description Sulfur hexafluoride is an ultrasound contrast agent indicated for use •in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms •in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients
Indications and Usage Echocardiography: Sulfur hexafluoride is indicated for use in adult patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricularendocardial border. Ultrasonography of the Liver: Sulfur hexafluoride is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB11104
KEGG ID D05962
MeSH ID D013459
PubChem ID 17358
TTD Drug ID D0K0MI
NDC Product Code 0270-7097; 0270-7099
UNII WS7LR3I1D6
Synonyms Sulfur Hexafluoride | Hexafluoride, Sulfur
Chemical Information
Molecular Formula F6S
CAS Registry Number 2551-62-4
SMILES FS(F)(F)(F)(F)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Acute myocardial infarction24.04.04.001; 02.02.02.001--Not Available
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Arrhythmia02.03.02.001--Not Available
Asthenia08.01.01.001--Not Available
Back pain15.03.04.005--
Blood glucose increased13.02.02.002--Not Available
Bone disorder15.02.04.004--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.009--Not Available
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Coronary artery disease02.02.01.001; 24.04.04.006--Not Available
Death08.04.01.001--
Dermatitis23.03.04.002--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dysgeusia07.14.03.001; 17.02.07.003--
Eye disorder06.08.03.001--Not Available
Fatigue08.01.01.002--
Feeling hot08.01.09.009--Not Available
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypotension24.06.03.002--
Immune system disorder10.02.01.001--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Injection site reaction12.07.03.015; 08.02.03.014--
The 1th Page    1 2    Next   Last    Total 2 Pages